BILL (NYSE: BILL) and Billtrust today announced they have launched the first live pilot to enable trusted AI agents to ...

The presentations cover two FDA-approved antibiotics marketed by Innoviva Specialty Therapeutics, ceftobiprole (ZEVTERA ®) and zoliflodacin (NUZOLVENCE ® ), and represent the company’s ongoing ...

For those who have memorized the knowledge of infectious disease laws, antimicrobial drugs, and pathogens, but still mix up ...

Delve Bio launched Delve Detect Plasma, a blood-based mNGS assay that detects over 68,000 pathogens with next-day results, ...